testo-alternativo
New Frontiers in Genitourinary Care

Inside Nephrology: A Weekly Review

Nefrologia

New Frontiers in Genitourinary Care

This week, we explore the evolving intersection of nephrology and urology—from advances in genitourinary cancer treatments to breakthroughs in benign prostatic hyperplasia management and neuromodulation. We discuss the trade-offs between survival and quality of life, highlight promising innovations like closed-loop systems and radiomics, and revisit the legacy of an early pioneer in integrative care.

Login or Register to listen to this episode

Bibliography

Singh D, Nguyen T, Burnam P, et al. Benign prostatic hyperplasia and sexual dysfunction: impact of new therapies. Curr Urol Rep. 2025;26(1):49. doi:10.1007/s11934-025-01279-z. PMID: 40490610.


Bergmann L, Albiges L, Ahrens M, et al. SUNNIFORECAST trial: ipilimumab/nivolumab vs standard care in non-clear cell RCC. Ann Oncol. 2025;36(7):796-806. doi:10.1016/j.annonc.2025.03.016. PMID: 40180121.


Szalontai J, Szarvas T, Miszczyk M, et al. Toxicities of PARP inhibitors in GU cancers. Curr Opin Urol. 2025;35(4):467-471. doi:10.1097/MOU.0000000000001297. PMID: 40336260.


Wang Y, Chen Y, Wang J. Tumor microenvironment in prostate cancer immunometabolism. Biomolecules. 2025;15(6):826. doi:10.3390/biom15060826. PMID: 40563466.


Liu R, Lu J, Liu J, et al. Macrophages in prostate cancer: dual roles in tumor biology. J Transl Med. 2025;23(1):615. doi:10.1186/s12967-025-06519-x. PMID: 40457341.


Vogel K, Nakib N. Sacral neuromodulation for neurogenic bladder. Curr Urol Rep. 2025;26(1):52. doi:10.1007/s11934-025-01280-6. PMID: 40549020.


St-Laurent MP, Bochner B, Catto J, et al. Treatment burden and QoL in GU malignancies. Eur Urol. 2025;88(1):11-20. doi:10.1016/j.eururo.2024.11.026. PMID: 39706786.


Wicaksono MH, Sugianto R, Duarsa GWK. Sexual outcomes post-vasectomy: systematic review. Arch Ital Urol Androl. 2025;97(2):13644. doi:10.4081/aiua.2025.13644. PMID: 40390510.


Gnanapragasam VJ. Clinical risk stratification in localized prostate cancer. Curr Opin Urol. 2025;35(4):426-431. doi:10.1097/MOU.0000000000001294. PMID: 40314071.


Nebe J, Krischel M. Dora Gerson: Jewish urologist persecuted under Nazism. Urologie. 2025;64(7):686-695. doi:10.1007/s00120-025-02614-5. PMID: 40478450.

Comments

Please Login to leave a comment.

No comments yet. Be the first to comment!